| Nereus Medical Ltd |
| Registered number: |
07758655 |
| Balance Sheet |
| as at 30 September 2025 |
|
| Notes |
|
|
2025 |
|
|
2024 |
| £ |
£ |
| Fixed assets |
| Intangible assets |
3 |
|
|
6,893 |
|
|
3,151 |
| Tangible assets |
4 |
|
|
4,333 |
|
|
1,971 |
|
|
|
|
11,226 |
|
|
5,122 |
|
| Current assets |
| Stocks |
|
|
9,900 |
|
|
11,700 |
| Debtors |
5 |
|
284 |
|
|
552 |
| Cash at bank and in hand |
|
|
23,709 |
|
|
10,386 |
|
|
|
33,893 |
|
|
22,638 |
|
| Creditors: amounts falling due within one year |
6 |
|
(24,592) |
|
|
(24,693) |
|
| Net current assets/(liabilities) |
|
|
|
9,301 |
|
|
(2,055) |
|
| Total assets less current liabilities |
|
|
|
20,527 |
|
|
3,067 |
|
|
| Provisions for liabilities |
|
|
|
(823) |
|
|
(375) |
|
|
| Net assets |
|
|
|
19,704 |
|
|
2,692 |
|
|
|
|
|
|
|
|
| Capital and reserves |
| Called up share capital |
|
|
|
100 |
|
|
100 |
| Profit and loss account |
|
|
|
19,604 |
|
|
2,592 |
|
| Shareholders' funds |
|
|
|
19,704 |
|
|
2,692 |
|
|
|
|
|
|
|
|
| The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006. |
| The members have not required the company to obtain an audit in accordance with section 476 of the Act. |
| The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. |
| The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies. |
|
|
|
|
| Dr R Hemingway |
| Director |
| Approved by the board on 23 June 2026 |
|
| Nereus Medical Ltd |
| Notes to the Accounts |
| for the year ended 30 September 2025 |
|
|
| 1 |
Accounting policies |
|
|
Basis of preparation |
|
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard). The financial statements are presented in sterling which is the functional currency of the company and are rounded to the nearest £. |
|
|
Turnover |
|
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the rendering of services. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. |
|
|
Tangible fixed assets |
|
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows: |
|
|
Plant and machinery |
over 4 years |
|
|
Debtors and creditors receivable/payable within one year |
|
Debtors and creditors with no stated interest rate and receivable and payable within one year are recorded at transaction price. Any losses from impairment are recognised in the profit and loss account in other administrative expenses. |
|
|
Taxation |
|
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted. |
|
|
Provisions |
|
Provisions (ie liabilities of uncertain timing or amount) are recognised when there is an obligation at the reporting date as a result of a past event, it is probable that economic benefit will be transferred to settle the obligation and the amount of the obligation can be estimated reliably. |
|
| 2 |
Employees |
2025 |
|
2024 |
| Number |
Number |
|
|
Average number of persons employed by the company |
1 |
|
1 |
|
|
|
|
|
|
|
|
|
|
| 3 |
Intangible fixed assets |
£ |
|
Patents and trademarks: |
|
|
Cost |
|
At 1 October 2024 |
4,595 |
|
Additions |
5,410 |
|
At 30 September 2025 |
10,005 |
|
|
|
|
|
|
|
|
|
|
Amortisation |
|
At 1 October 2024 |
1,444 |
|
Provided during the year |
1,668 |
|
At 30 September 2025 |
3,112 |
|
|
|
|
|
|
|
|
|
|
Net book value |
|
At 30 September 2025 |
6,893 |
|
At 30 September 2024 |
3,151 |
|
|
|
|
|
|
|
|
|
|
Patents and trademarks are being written off in equal annual instalments over its estimated economic life of 6 years. |
|
|
| 4 |
Tangible fixed assets |
|
|
|
|
|
|
|
|
Plant and machinery etc |
| £ |
|
Cost |
|
At 1 October 2024 |
11,016 |
|
Additions |
4,392 |
|
Disposals |
(4,955) |
|
At 30 September 2025 |
10,453 |
|
|
|
|
|
|
|
|
|
|
Depreciation |
|
At 1 October 2024 |
9,045 |
|
Charge for the year |
1,618 |
|
On disposals |
(4,543) |
|
At 30 September 2025 |
6,120 |
|
|
|
|
|
|
|
|
|
|
Net book value |
|
At 30 September 2025 |
4,333 |
|
At 30 September 2024 |
1,971 |
|
|
| 5 |
Debtors |
2025 |
|
2024 |
| £ |
£ |
|
|
Prepayments and accrued income |
284 |
|
451 |
|
Other debtors |
- |
|
101 |
|
|
|
|
|
|
284 |
|
552 |
|
|
|
|
|
|
|
|
|
|
| 6 |
Creditors: amounts falling due within one year |
2025 |
|
2024 |
| £ |
£ |
|
|
Taxation and social security costs |
3,905 |
|
2,064 |
|
Other creditors |
20,687 |
|
22,629 |
|
|
|
|
|
|
24,592 |
|
24,693 |
|
|
|
|
|
|
|
|
|
|
| 7 |
Other information |
|
|
Nereus Medical Ltd is a private company limited by shares and incorporated in England. Its registered office is: |
|
Maples Exton Lane |
|
Exton |
|
Exeter |
|
Devon |
|
EX3 0PN |